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Background. Cleft palate is associated with recurrent otitis media with eﬀusion and hearing loss. This study analysed the way these
patients’hearingismanagedinAlderHeyChildren’sHospital.Method.Aretrospectiveauditwascarriedoutoncleftpalatepatients
in Alder Hey Children’s Hospital. Audiology assessment and treatment options were reviewed. Comparisons were made between
the use of ventilation tubes (VTs) and hearing aids (HAs). The types of cleft, types of hearing loss, and the management output
of the audiology regions were also reviewed. Results. The audiology assessments of 254 patients were examined. The incidence of
VT insertion in this group of patients was 18.9%. The hearing aid incidence rate was 10.1%. The VT-related complication rate was
25.5% and the HA related complication rate was 9.1%. Conclusion. The data demonstrates that both treatments are viable, and a
new protocol which combines the short term beneﬁt of VT insertion with the lower complication rate of HA is required.
1.Introduction
Persistenceofﬂuidinthemiddleear,withanintacttympanic
membrane, for a continuous period of three months or
more is categorized as otitis media with eﬀusion (OME) [1].
When the ﬂuid persists, treatment may be required to re-
duce the impact of the conductive deafness, which can have
consequencesregardingthechild’slanguage,educationaland
social development.
Certain individuals, such as those with cleft palate, are
more likely to develop OME. The association between two
has been well documented since Alt described the presence
of otorrhoea in a child with cleft palate in 1879 [2]. Paradise
etal.deducedthatmiddleeardiseaseprobablydevelopsinall
cleft palate patients [3]. However, more recent studies have
conﬁrmed this ﬁgure to be around 90% [4–6].
Initially, repair of the cleft palate does slightly improve
the ventilatory function of the eustachian tube. However,
only after the adolescent growth phase, which also improves
tubal function, does the incidence of OME greatly decrease
[7].
The high incidence of OME in cleft palate patients led to
the conclusion that prophylactic treatment with ventilation
tubes (VTs) would solve the inevitable hearing loss and
prevent the sequelae of OME including cholesteatoma for-
mation, retraction pockets, ossicular ﬁxation, and atelectasis
[8]. Studies have conﬁrmed that early intervention with VTs
does provide an appreciable beneﬁt with regards to short-
term hearing, between 6–12 months [9–11]. This regimen
usually requires VTs to be inserted in the ﬁrst year of life, at
the same time as cleft palate surgery to reduce further oper-
ations [9]. However, currently the use of prophylactic VTs
is being heavily scrutinised due to the associated complica-
tions; perforations, otorrhea, eardrum atrophy, vgranulation
tissue,andtympanosclerosis(whichhavebeenreportedtobe
ashighas80%[8]).Otherstudieshaverevealedthatchildren
who undergo multiple VT insertions increase their risk of
conductive hearing loss in the long term [12].
Maw et al. showed that 50% of OME resolves spontane-
ously within 3 months and that 90% of middle ear eﬀu-
sions occurring following acute suppurative otitis media
resolve spontaneously [13, 14]. In view of this and the VT
complication rate, a more conservative approach to treat-
ment has ensued. Hearing aids (HAs) are now oﬀered as
an alternative to VTs, and insertion of VTs should only be
considered in light of careful otological and audiological
assessment [15].2 International Journal of Otolaryngology
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Figure 1: Audiological care pathway for children with cleft palate in the mersey region.
The audiological assessment for cleft palate patients is
continuous until the patient is discharged from the care of
the cleft and audiology team. It begins with the newborn
screening programme and regular audiology appointments
follow, so that any hearing loss can be treated responsively.
Even if the result from the tests indicates a clear response,
careful prolonged assessment is required (Figure 1).
2. Methods
The primary outcome of the study was to compare the
hearing before and after the intervention(s) of HAs or VTs.
The secondary outcomes will examine a wide range of
outcomes including:
(i) Distribution of cleft types.
(ii) The types of syndromes, sequences, and anomalies
found in the sample population.
(iii) Complication rates of the treatments.
(iv) Types of hearing losses within the sample.
(v) Whether the audiology centre predisposes to the
treatment outcome (HA/VT).
Numerous variables were collected from the available
data source for each patient (the appendix). The data was
obtained from both primary sources (medical records) and
secondary sources such as Meditech and audiology letters.
This data was captured using a purpose-designed Microsoft
Access database form. Chi-squared and Fisher’s exact test,International Journal of Otolaryngology 3
used to analyse the nominal data set using SPSS. P values
≤ 0.05, were considered statistically signiﬁcant.
Audiological data was categorised according to the
average degree of hearing across the 4 frequencies of 250Hz,
500Hz, 1kHz, and 2kHz obtained through primary or sec-
ondary analysis (the verdict of the audiologist). The categor-
ies for the degree of hearing loss ranged from normal <20dB
to profound >95dB (derived from the British Association of
Audiologists).
As a result of the breadth of the data, the dataset encom-
passes periods where routine grommet insertion was used
and more recently a selective procedure. In the latter period,
the decision for VT insertion and HAs was made at the dis-
cretion of the audiologist and the ENT surgeon using the
clinical triad of: (i) audiological evidence of hearing loss
>20dB, (ii) recurrent otitis media with persistent eﬀusion
± anatomical abnormalities, and (iii) parental preference
regarding hearing management.
Foranychildtobeincludedinthedataset,theymusthave
had a cleft palate and be under the care of the cleft team.
This excluded several patients with noncleft velopharyngeal
insuﬃciency and or with cleft lip only. Patients who moved
to outside the catchment area, discharged from the care of
the cleft palate team, were deceased, and those who did not
have aided hearing levels for HAs were excluded.
Institutional ethical approval came from the Alder Hey
Hospital audit department.
3. Results
A retrospective audit was carried out on 254 consecutive
children; under the care of the cleft palate team at Alder hey
Children’s hospital. The patients attended one of 14 audio-
logy centres in north west England, North Wales, and the Isle
of Man between the dates of 24/10/2009 to 08/03/2011.
After the exclusion criteria, out of the 254 patients,
217 patients remained. Of which 63 were placed in the
intervention group (HA(s)/VTs), and 154 were assigned to
the watchful waiting group.
The length of follow up in the intervention group varied
from patient to patient. This was the time that had elapsed
between their last pre-intervention audiology data record
and their latest audiology data. This systematic approach
y i e l d e da na v e r a g ef o l l o w - u pt i m eo fa r o u n d3y e a r s .
3.1. Primary Outcome. T h ep r i m a r yo u t c o m ev a r i a b l eo f
hearing before and after the intervention was examined
for each of the two intervention outcomes (Table 1). Only
40/63 patients were investigated, due to the timing of the
intervention treatment (patients who had just received a new
intervention had yet to have a postoperative assessment).
Even so, this provided a value P = 0.47 indicating that
in fact there was no signiﬁcant association between hearing
outcome and treatment, and by scrutinising the diﬀerences
between the pre- and post values it can be deduced that both
improve hearing outcomes.
Table 1: Comparing treatment outcomes by way of diﬀerences in
pre- and post-intervention hearing.
Diﬀerence between preintervention and postintervention
hearing versus hearing intervention
Hearing intervention
Total HA VT
Diﬀerence between
preintervention
and
postintervention
hearing
−1 022
0257
1 8 12 20
229 1 1
T o t a l 1 22 84 0
Table 2: Treatments Instituted. VT→HA = ventilation tubes ﬁrst
followed by hearing aids. HA→VT = Hearing aids ﬁrst followed by
ventilation tubes.
Hearing interventions past and present
Frequency Percent (%)
HA 16 25.4
VT 39 61.9
VT→HA 6 9.5
HA→VT 2 3.2
Total 63 100.0
3.2. Secondary Outcomes
3.2.1. VT/HA Statistics and Complications. The VT insertion
rate was 18.9% (41/217), and the HA incidence rate was
10.1% (22/217). The total number of children who at
some point had or were still wearing HAs was 38.1%
(24/63). A similar analysis of VTs yielded 74.6% (47/63). The
overlappingdiscretionwasduetothe6patientswhohadVTs
ﬁrst, followed by HA(s) and the 2 patient who had HA(s)
ﬁrst, followed by VTs (Table 2).
A large proportion of patients, 34.9% (22/63), had VTs
inserted at the same time as cleft surgery.
Of the 22.2% (14/63) patients that suﬀered from a
complication 12 having VTs. Considering 47 patients had
VTs at the time of the complications, the VT-related
complication rate is 25.5% (12/47). The main complications
derived VT insertions were tympanosclerosis (5 patients),
perforation (5 patients), otalgia (2 patients), and retraction
pocket(s) (1 patient). In total, this equates to 13 patients, the
overlapping discrepancy is due to one of the patients having
both perforation and tympanosclerosis.
Similarly the HA related complication rate was 9.1%
(2/22). The only recorded complication was noncompliant
whereby the child would constantly remove the HA device.
A chi-square test of the current interventions and the
complications would mask those complications that were
due to previous VTs. When the data was reorganised to
reﬂect when the complication was detected, a chi-square
value of P<0.05 was obtained indicating that the VTs were
signiﬁcantly associated with complications recorded.4 International Journal of Otolaryngology
Table 3: Comparing treatment outcomes by way of diﬀerences in
pre- and post intervention hearing.
Hearing loss type versus hearing intervention
Hearing Intervention
Total HA VT
Hearing
loss type
Conductive 17 39 56
Sensorineural 2 0 2
Mixed 3 2 5
Total 22 41 63
Table 4: Distribution of cleft types in the sample. UCLP: unilateral
cleft lip and palate; BCLP: bilateral cleft lip and palate.
Type of Cleft Frequency Percentage (%)
Soft palate 55 25.34
Hard palate
and soft
palate
61 28.11
UCLP 61 28.11
BCLP 33 15.21
Submucous 7 3.23
Total 217 100
Table 5: Distribution of cleft types in the intervention group.
UCLP: unilateral cleft lip and palate; BCLP: bilateral cleft lip and
palate.
Type of cleft
Frequency Percent (%)
Soft palate 19 30.2
Hard and soft palate 15 23.8
UCLP 17 27.0
BCLP 11 17.5
Submucous cleft 1 1.6
Total 63 100.0
3.2.2. Hearing Loss Types. The predominant type of hearing
lossintheinterventiongroupwasconductive,whichaﬀected
88.9% (56/63) of patients, whilst 7.9% (5/63) patients in the
studyhadamixedhearinglossandaminorityof3.2%(2/63)
had a permanent sensorineural loss predominantly aﬀecting
their hearing. All sensorineural hearing loss patients received
HAs and most conductive hearing loss patients received VTs
(Table 3).
3.2.3. Type of Orofacial Clefts. The types of clefts are
shown for the whole sample of 217 patients (Table 4)a n d
the intervention group (Table 5). Both samples reﬂected a
similar distribution of cleft types with a submucous cleft
being the most rare and unilateral cleft lip and palate, hard
palateonlyandhardandsoftpalatebeingthemostpopulous.
The type of cleft was compared to the severity of prein-
terventional hearing loss. This returned a value of P>0.05
indicating that the type of cleft does not signiﬁcantly aﬀect
the severity of hearing loss that the patient will experience.
Table 6: Associated syndromes, associations and nonrandom
anomalies. PR: Pierre Robin sequence.
Syndrome/sequence/association
Frequency Percent (%)
No syndrome 46 73.0
PR 8 12.7
Charge 1 1.6
Crouzons 1 1.6
Digeorge 1 1.6
Goldenhar 1 1.6
Kabuki 2 3.2
Orofacial digital 1 1.6
Van der woude 1 1.6
Stickler and PR 1 1.6
Total 63 100.0
Table 7: Audiology centres and type of treatment outcomes.
Audiology centres versus hearing interventions
Hearing intervention
Total HA VT
Alderhey 0 3 3
Preston 13 6 19
Southport 2 3 5
Chester 0 1 1
Crewe 1 3 4
Audiology
centres Wirral 1 6 7
St Helen 1 8 9
Isle of Man 0 1 1
Wrexham 2 5 7
Warrington 1 5 6
Wigan 1 0 1
Total 22 41 63
3.2.4. Syndromes/Sequences and Anomalies. A signiﬁcant
proportion of cleft palate patients had associated syndromes,
sequences, and nonrandom associations. Just over a quarter,
27% (17/63), of patients that required interventions had a
syndrome/sequence/association (Table 6) .T h eP i e r r eR o b i n
sequencewasthemodalconditionaccountingfor47%(8/17)
of the syndromes/sequences/associations.
3.2.5. Audiology Regions and the Type of Interventions Imple-
mented. Since the introduction of the NICE guidelines in
2008, and with the majority of the patients being treated
after the introduction of the guideline, it was intriguing to
see whether there were discrepancies between the audiology
regions and the type of treatments implemented. Across
the board of 63 patients, there were 11 audiology centres
involved (Table 7). After the current type of treatment was
analysed against the region, a P value of 0.04 was obtained,
which suggested that there was a signiﬁcant link between the
two.International Journal of Otolaryngology 5
Table 8
Variable Explanation
Syndromes/sequences/associations All anomalies associated with orofacial clefts were collected.
Preintervention hearing outcome For those who received a management intervention, this would be the last available audiological
assessment prior to the intervention.
Postintervention hearing outcome This would be the most recent audiological assessment after the intervention.
Type of cleft This was classiﬁed as cleft of soft palate, cleft of hard and soft palate, unilateral cleft lip and palate,
bilateral cleft lip and palate and cleft lip only.
Complications The complications recorded were those that occurred during or directly after the intervention.
Regions This would be categorised according to one of the 14 centres in the locality.
Type of intervention The expanded data set is HA, VT, HA+ VT, HA→VT, VT→HA, and watchful waiting.
Type of hearing loss One of sensorineural, mixed, and conductive.
4. Discussion
This study is comparable with those of Maheshwar et al.,
Phua et al., and Shaw et al. [2, 16, 17]. Comparisons with
these studies must be made with caution due to the diﬀerent
clinical protocols and study designs implemented. However,
it is universally accepted that children with cleft palate have
a high incidence of middle ear disease, around 90%, before
the age of 6. Up to 45% of these children will suﬀer from
recurrent ear infections [18].
Many studies have concentrated their eﬀorts on one type
of hearing management, namely, ventilation tubes. However,
am o r ec o n s e r v a t i v ea p p r o a c hh a sb e g u nt oi n ﬂ u e n c eO M E
management due to the ability of spontaneous resolution,
and this is reﬂected with the introduction of hearing aids in
this study.
The incidence of grommet insertion was 18.9% (41/217).
This is lower than previous studies, for example, Shaw et al.
28% and Robertson et al. 26%, but it is comparative to that
of Maheshwar et al. 17.1% [2, 17, 19]. These discrepancies
may have arisen due to the outcomes of the diﬀerent studies
and the attitudes and clinical protocols of the time.
However, 46.8% (22/47) of the cleft palate patients
w h oh a do rs t i l lh a v eV T ( s )u n d e r w e n tg r o m m e ti n s e r t i o n s
during a palatal repair or revision. This encompasses a range
from 2002–2011 that reﬂects the earlier view of wanting to
reduce the operative risk together with the present view that
VTs should only be inserted at the time of cleft palate surgery
if the child has glue ear, not as a prophylaxis.
Out of the 47 patients who had or still have VTs, 7
patients (14.9%), all born before 2007, required VT reinser-
tions suggesting that the ventilation tubes are in fact inef-
fective at preventing reinfection once shed. This study agrees
with Merrick et al. (28%) assuming that the ﬁgures are
relative to the change in clinical protocols [20].
The HA incidence rate was 10.1% (22/217). Interestingly,
27.2%(6/22)ofpatientshadpreviousVTsbeforebeingman-
aged with HAs. This may be linked to the fact that patients
who undergo a greater number of grommet insertions have
a higher number of tympanic membrane deformities [16].
This is illustrated by 28.6% (2/7) patients who underwent
repeated grommet insertions, developing perforations of the
tympanic membrane.
Approximately 19.0% (12/63) patients who required an
intervention developed visible or symptomatic complica-
tions upon audiological assessment by way of audiograms,
tympanograms, and otoscopy. This is slightly higher but
comparabletoMaheshwaretal.(17.1%),butalotlowerthan
some aforementioned studies [8]. VTs were also found to be
signiﬁcantly linked to the complications. However, one has
to bear in mind that a false negative picture may bias the
results for two reasons. Firstly, because of the sample size
used with regards to the intervention group and secondly,
because of hearing aid complications such as compliance,
wax build up, or ear infections not being fully documented
as they may have been treated by the General Practitioner
locally or are not recognised as a possible complication of
the device, leading to a false negative picture.
Similarly with regards to the type of hearing loss and the
treatment implemented one has to factor in things such as
childrenacceptinghearingaidsandnotpullingthemoutand
parents’ not wanting their children to have a visible hearing
aid. This means that for a conductive or mixed hearing loss
HAs or VTs can be used. Although for sensorineural hearing
loss, HAs are solely used.
Due to the uncertainty of the optimum treatment
plan, there are diﬀerent preferences between the audiology
centres. For example, in this dataset the audiology centre
in Preston dispenses the highest number of hearing aids
whencomparedtotheWirralandStHelenaudiologycentres
whichpreferredVTs.Thishighlightsthelackofuniformityin
the treatment protocol.
The primary outcome measure of hearing outcome in
relation to HAs and VTs indicated that there was no signiﬁ-
cant link between the two variables. According to this study,
in terms of audiological improvement, both types of treat-
ment are on par with each other.
5. Conclusion
The results from this study show lower VT complication
rates when compared to other similar studies. This may
be linked to the greater implementation of HAs, which are
equal to the VTs in terms of improving audiological out-
come. On the whole, HAs are also better tolerated than VTs6 International Journal of Otolaryngology
by the majority of patients, with noncompliance being the
sole complication issue.
The disparity in the ﬁeld is reﬂected by some audiology
centres preferring either HAs or VTs, and this echoes the
current knowledge based on this topic. However, it is worth
considering that factors such as parental decisions, speech
and language outcomes, and cost eﬀectiveness will inﬂuence
the treatment outcome meaning that complete uniformity
with regards to a stringent treatment protocol will not be
attainable.
Appendix
See Table 8.
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